Foreign manufacturers cut production of vital and essential medicines because of the substantial depreciation of the ruble, "Vedomosti".

Top-manager of one of the foreign drugmakers told the newspaper that the company canceled or reduced orders at factories in several names - up to 20% of sales - as a 30 percent increase in the dollar makes production unprofitable.